In a 26-0 vote, the Senate Finance Committee Nov. 8 reported the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, bipartisan legislation that includes AHA-supported provisions to improve access to behavioral health care and delay Medicaid disproportionate share hospital reductions.

The AHA-supported provisions would provide Medicare incentives to integrate behavioral health and primary care; delay certain Medicaid disproportionate share hospital payment reductions for two years; and permanently grant state Medicaid programs the option to receive federal matching payments for substance use disorder treatment provided in certain institutions for mental diseases. The legislation also would ensure timely communication regarding telehealth and interstate licensure requirements, and extend certain Medicare payment provisions for physicians and clinical laboratory services.

Related News Articles

Headline
The AHA Sept. 15 expressed support for the Ensuring Access to Essential Providers Act, legislation that would require Medicare Advantage plans to cover…
Headline
A Gallup report published Sept. 9 found that nearly 48 million Americans currently have or are being treated for depression. The total, which equals 18.3% of…
Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
The House Energy and Commerce Subcommittee on Health Sept. 10 advanced the Title VIII Nursing Workforce Reauthorization Act (H.R. 3593), AHA-supported…
Headline
The House Appropriations Committee Sept. 9 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services, Education…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…